Safety and efficacy of uninterrupted periprocedural rivaroxaban in patients undergoing atrial fibrillation catheter ablation: A metaanalysis of 1,362 patients

Int J Cardiol. 2016 Jan 15:203:906-8. doi: 10.1016/j.ijcard.2015.11.085. Epub 2015 Nov 30.

¹ Division of Cardiology, Lehigh Valley Health Network, Allentown, PA, United States. Electronic address: [email protected].
² Department of Medicine, Sinai Hospital of Baltimore, Johns Hopkins University, Baltimore, MD, United States.
³ Department of Medicine, Division of Cardiology, Einstein Healthcare Network, Philadelphia, PA, United States.
⁴ Division of Cardiology, Lehigh Valley Health Network, Allentown, PA, United States.
⁵ Texas Cardiac Arrhythmia Institute at St. David's Medical Center, Austin, TX, United States.

No abstract available

Keywords: Anticoagulation; Atrial fibrillation ablation; Rivaroxaban; Thromboembolism.

Publication types